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An Isolated Complete Intestinal Transplantation in an Adult: 
A Complicated Postoperative Course 
Case presentation: 
KAREEM M. ABr-b~1AdaI SATORU Tooo, A'IDREAS TZAKls. 
K.£N]IRO NAKAMURA, HARlAN WRIGHT, JOHN FUNG, JORGE REvEs, 
ROBERT GORDON, DAVID H. V Al'J THIEL AND THOr-"IAS E. STARZL 
Piltsburgb 
A 31-year-old black male was referred to the Universiry of 
Pittsburgh Medical Center five months after he lost his entire small 
bowel. (Fig. 1) The patient had multiple gun-shot injunes to the 
abdomen and was placed on total parenteral nutrition (TPN) after 
unsuccessful multiple anempts to reconstruct the main superior 
mesemeric vessels. Because continuiryof the gastrointestinal tract 
was not restored at the time of surgery. induced vomiting was the 
only wav to drain the gastroduodenal and biliary secretions. At 
the lime of initial evaluation. the biochemical liver function tests 
were good and the patiem was accepted as a candidate for an 
isolated small intestinal transplantation (SBTx). 
Donorlnjormarion. On May 2.1990, a suitable donor became 
available and the whole small bowel was transplanted. The donor 
was young (36 years old). Caucasian. of the opposite sex and 
smaller in size compared to the recipient. The graft was ABO 
identical (0 +ve) , HLA incompatible and the cytotoxic cross 
match was negative. Selective decontamination of the donor's gut 
was attempted utilizing Amphotericin B. gentamycin and poly-
myxin E with no efforts to alter the graft lymphoreticular tissue 
with either OKT3, AlG or other modalities. The whole small 
bowel was harvested by Dr. Starzl and was preserved by simple 
immersion in an ice bath without vascular flushing. The intestinal 
lumen was irrigated with cold lactated Ringer's solution. and the 
graft was preserved for 10.5 hours. 
Recipient Operarion. Extensive adhesions were evident at the 
time of surgery because of the previous multiple abdominal 
operations. The gallbladder was injured during kocherization of 
the duodenal stump and dissection of the transverse colon which 
necessitated cholecystectomy. The technique of the graft im-
plantation was similar to that originally used by Lillehei in dogs 
more than 30 years ago, except that arterialization was with a free 
segment of the recipient internal iliac artery that was interposed 
between the superior mesenteric artery (SMA) of the graft and the 
recipient infrarenal aorta. (Fig. 2) After tedious dissection. the 
distal stump of the recipiem superior mesemeric vein (SMV) was 
found and anastomosed to the graft SMV using a segment of the 
donor iliac vein as an interposition graft. The proximal segment 
of the graft jejunum was anastomosed side-to-side to the recipient 
duodenal stump. and the intestinal graft was vented at both ends 
by a chimney-rype proximal jejunostomy and distal ileostomy. 
Both vents allowed closed monitoring of the graft and adequate 
early decompression of the GI tract. COntinuiry of the alimentary 
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canal was completely restored in two stages. The proximal jejunal 
stoma was first closed 8 weeks after transplant and the terminal 
vent was then excised at 16 weeks with construction of a side-to-
side ileocolic anastomosis. 
Postoperarive Management. The basic immunosuppressive 
therapy was FK 506. The drug was initially given intravenous Iv 
twice per day with a toral dose of 0.15 mg/kg (infused over 4 
hours). Enteral administration was started on postoperative dav 
(POD) 18 with a beginning dose of 0.3 mglkglday. (Fig. 3) Dose 
adjustments and discontinuance of intravenous FK 506 therapy 
were made based upon the qualiry of intestinal graft function. 
daily FK 506 trough plasma levels, oral FK 506 pharmacokinetic 
studies, evidence of graft rejection and development of renal 
Figure 1: GI series and barium enema before small bowel transplantation. The 
residual GI tract consisted of the stomach. the duodenal loop that ended 
blindly and the left colon. 
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dysfunction. Maintenance steroid therapy was started on POD 14 
with an initial dose of 30 mg/day which was gradually reduced 
to 10 mg. Fifteen months after transplantation a low dose of 
azathioprine (0.8 mg/kg/day) was added to the previous inunu-
nosuppressive regimen. 
Intestinal decontamination was adopted for the first six 
postoperative weeks using a combination of Amphotericin B, 
gentamycin and polymyxin E on a four times daily regimen. The 
patient also received systemic ampicillin and Cefotaxime as 
prophylactic antibiotics during the first five postoperative days. 
With each rejection episode, selective decontamination was 
reinstiruted for a period of one to two weeks and guided by 
frequent blood and quantitative stool culrures. 
Monitoring of intestinal functions and detection of graft 
rejection was based primarily on clinical, histopathologic, 
endoscopic, radiologic, anthropometric and metabolic param-
eters. 
Despite the stonny postoperative course with sluggish re-
sumption of the gastrointestinal functions that required protracted 
initial hospitalization (five months) and repeated readmissions 
(six times). the patient is still alive 18 months after transplantation 
with satisfactory graft functions. The remarkable events that 
complicated the patient management and his postoperative care 
are the follOWing: 
Temporary Liver Dysfunction. Before transplantation. there 
was no biochemical evidence of Significant liver dysfunction; 
nonnal serum bilirubin (0.7 mg/dL) , serum albumin (3.4 g/dL) 
and prothrombin time 02.8 seconds). The liver enzymes were 
slightly elevated with a level of 72 lUlL (SGOn, 84 lUl L (SGPTI. 
103 lUlL (alkaline phosphatase) and 331 lUlL (i>-GTP) The liver 
biopsy at the time of surgery showed centrilobular steatosis with 
cholestasis, arteriolar thickening and hemosiderosis. On the third 
postoperative day, the total serum bilirubin increased to 4.4 mg! 
dL (direct: 2.9 mg!dL) with Significant prolongation of the 
prothrombin time 07.6 seconds). There were no concomitant 
skin lesions suggestive of graft-versus-host disease and liver 
biopsy was not obtained. The operative requirement for blood 
transfusion was minimal, and the patient did not receive any 
anticoagulant therapy. Recovery was gradual. and all values 
returned to the normal range by the end of the second POStOP-
erative week. 
Permanent Renal Failure. Kidney function was nonnal at the 
time of SBTx with BUN of 19 mg/dL and serum creatinine of 0.4 
mg/dL. A signiftcant reduction in urine output with a steady 
increase in both parameters was noticed during the first 10 
postoperative days. On the 14th postoperative day hemodialysis 
was started due to severe renal insufftciency. (Fig. 3) At that time 
the patient had a severe rejection episode with interminent 
hypotension and high FK 506 trough plasma levels and received 
a combination of different nephrotoxic antibiotics including 
amphotericin B. Renal ultrasound which was done periodically 
showed Significant reduction in the size of both kidneys with no 
evidence of renal vascular occlusion. The patient is currently on 
hemodialysis awaiting kidney transplantation. 
Graft Rejection. Recurrent episodes of intestinal graft rejection 
developed in both the early and late postoperative periods. 
Figure 2 (left) . The graft SMA and SMV are connecled to the reCipient 
inlrarenal aorta and SMV, respectively, using interposition grafts. The two 
ends of the intestinal graft are exteriorized by chimney enterostomy at the 
upper and lower right quadrants of the abdomen. 
Figure 3 (below). The postoperative clinical course with close monitoring of FK 
506 doses, drug trough plasma levels, serum creatinine and total bilirubin. 
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Figure 4: Histological monitoring of intestinal graft rejection . A) Prominent rejection with a mixed cellular infiltrate composed of activat~d lymphocytes and plasma 
cells . Epithelial damage at crypts and depletion at goblet cells are also evident (H&E, x480). B) Treated rejection with less cellular infiltrate and Intact crypts with 
normal goblet and Paneth cells (H&E. x480). 
(Tabte 1) The first endoscopic biopsy on POD 7 showed mild 
cellular infiltrates. cryptitis and villous edema. The patient was 
receiving fK '506 as the onlv immunosuppressive agent at that 
time and was running high drug plasma levels. On the evening 
of POD 14 . the patient developed high fever <39° 0. abdominal 
pain and high watery stomal output (> 3 L within 24 hours). On 
physical examination the abdomen was distended with infre-
quent bowel sounds and the mucosa of both the jejunal and ileal 
stomae was edematous and dusky in color. Emergent endoscopy 
showed edematous flat mucosa. diffuse hyperemia and multiple 
ulcerations particularly in the distal ileum. Multiple endoscopic 
biopsies were obtained and sent for histopathological examina-
tion . Meanwhile the patient started to develop mental confusion, 
hypotenSion and metabolic acidosis. Therefore treatment was 
initiated immediately with 2 gm Solumedrol and 10 cc of OKT3. 
[n the next morning, the diagnosis was histologically documented 
(Fig. 4A). another I gm Solumedrol was given and the patient 
continued to receive OKT3 for a total of seven days. Also, 
maintenance steroid therapy was started with a daily dose of 30 
mg. Recovery was clinically obvious within 24 hours. The 
endoscopic examination at the end of the OKT3 course revealed 
nonnal mucosal appearance and the obtained biopsies docu-
mented marked histological improvement. (Fig. 4B) On POD 37 
there was clear clinical evidence of another rejection episode but 
with minimal histological changes. Two grams of Solumedrol 
were then given with an increase in FK 506 doses. The subsequent 
endoscopic protocol biopsies declared another [WO episodes of 
mild histological graft rejection during the rest of the first initial 
Table 1 
Time, Severity and Treatment of Intestinal Graft Relectlon 
Total Histological Degree of Rejection 
Number (Postop. days, 
Biopsy Rejection None Mild Prominent 
22 10 21,28 7.59,71 14,66 
(45%) 35.37 92.437 
78,127 453.486 
151.177 569 
197,217 
247,378 
Figure 5: Erect abdominal films at the time of rejection. Notice the multiple 
fluid levels. 
Treatment of Relection 
(Postop. days' 
Steroid 
Increase FK-dose Bolus Recycle OKT322 
59 .92 14,35 166,437 14 
166 166,437 
569 
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Figure 6 Upper GI series of normal (A, above) and rejected (8, right) graft. 
Notice distention 01 the intestinal loops and effacement of the mucosal folds 
at the lime 01 rejection 
Figure 7: Endoscopic piclure of rejected small bowel graft (terminal ileum) 
showing partial sloughing of the intestinal mucosa and pseudomembrane 
formation . 
hospitalization period (five months), which were treated just with 
increases in FK 506 doses. (Table 1) 
On October 9, 1990, the patient was discharged from the 
hospital enjoying full unrestricted oral diet with no gastrOintesti-
nal complaints and normal endoscopic, histologic and metabotic 
studies. One week later, the patient was readmined with frequent 
copious vomiting, severe diarrhea, persistent abdominal pain and 
septic shock-like syndrome. The erea abdominal x-ray fLIms 
showed multiple fluid levels with no radiological evidence of 
pneumatosis or free air in the peritoneal cavity. (Fig. 5) The 
barium follow-through study demonstrated dilated edematous 
intestinal loops, prolonged transient time and abnormal mucosal 
panern with no signs of mechanical obstrUction. (Fig. 6) The 
endoscopic examination showed extensive sloughing of the 
intestinal graft mucosa (Fig. 7) and the histologic findings 
documented prominent rejection. On the day of admission the FK 
506 plasma level was undetectable « 0.1 ngirnL) and the patient 
admined that he stopped taking his irnrnunosuppressive drugs for 
the last five days. The patient was then immediately treated with 
1 gm Solumedrol and a steroid cycle together with the reinstitu-
tion of FK 506 therapy. The clinical, endoscopic, histologic and 
metabolic recovery of the graft was very slow with persistent 
histological evidence of intramural graft infection, 
pseudomembrane formation , abnormal d-xylose and vitamin E 
absorption tests. Six months later the graft biopsy showed intact 
intestinal mucosa and apparent normal villi. The last four 
endoscopic biopsies, however. showed variable degrees of focal 
cryptitis associated with persistent submucosaJhistopathologicaJ 
changes. 
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Infection. Despite the frequent clinical and/or histological 
intestinal graft rejections, the patient experienced only one 
episode of bacterial translocation. On POD 58 he developed high 
fever and hemodynamic evidence of fulminant systemic sepsis. 
Repeated blood cultures were positive for both Candidaalbicans 
and Enterococcusjaecalis. The same organisms were simulta-
neously isolated from multiple stool cultures at a concentration 
of greater than 109/ ccJ. Meanwhile, the intestinal graft biopsy 
showed mild acute cellular rejection with focal sloughing of the 
cell surface epithelium. The patient was successfully treated with 
the proper systemic antibiotics including a full course of 
amphotericin B, selective intestinal decontamination and aug-
mented immunosuppressive treatment. 
Graft DysfunctiOn. Recovery of the intestinal graft motility was 
clinically and radiologically evident after the first 10 postoperative 
days. The achievement of alimentation was a slow process, 
despite early initiation of both enteral feeding (POD 7) and oral 
FK 506 therapy (POD 19), requiring concomitant intermittent 
intravenous nutrition for almost eight months. (Fig. 3) The serial 
body weight measurements. d-xylose absorption test , fat diges-
tion. serum zinc and vitamin levels were optimal until the patient 
stopped his immunosuppressive treatment. Subsequent recovery 
of the graft was slow and incomplete requiring cyclic TPN 
therapy. 
The Question oj Chronic Rejection. The current nutritional. 
endoscopic, histologic and radiologic data are suggestive of 
chronic graft changes particularly in the distal ileum. Full thick-
ness biopsies and further longitudinal follow-up studies are 
necessary to establish the diagnosis of chronic rejection and 
determine the irreversibility of graft dysfunction. 
Commentary 
James Williams 
This paper presented by the group founded by Dr. Thomas 
Starzl illustrates the formidable barriers presented by intestinal 
transplantation. While the groups at London, Ontario. Chicago 
and Pittsburgh have shown that inclusion of the liver with an 
intestinal graft remarkably reduces the risk of bowel rejection, the 
isolated bowel graft appears to defy available immunosuppres-
sive therapy. The groups in France and Germany have reported 
patients with isolated intestinal grafts who have been freed of 
dependence on parenteral nutrition for variable periods of time, 
but the failures substantially outnumber the successes. 
Despite the use of high doses of potent immunosuppression 
in the patient described, doses which appear to have jeopardized 
the patient's renal function and exposed him to near lethal 
infection and despite inclusion of the entire immunosuppressive 
armamentarium available to the transplant surgeon (azathioprine. 
FK 506, corticosteroids, OKT3), this patient continued to relent-
lessly reject the bowel so that its functional integrity has been 
essentially lost. While these authors are to be commended for 
their tenacity and clinical skill in bringing this patient through 
these difficult complications and lUCidly describing the problems 
encountered. it appears that the tools currently available to alter 
human alloreactivity are inadequate to suppOrt the function of an 
intestinal allograft. As the new drugs, monoclonal antibodies and 
tolerance strategies expand the contemporary literature, the 
barriers to successful intestinal transplantation will gradually 
recede through the efforts of courageous patients and physicians 
such as described by Dr. Abu-Elmagd. 
